Status:
TERMINATED
Automated Breast Ultrasound Case Collection Registry
Lead Sponsor:
GE Healthcare
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
The contribution of automated breast ultrasound (ABUS) to the screening pathway for breast cancer is not fully understood. This prospective study aims to collect longitudinal data in women with dense ...
Eligibility Criteria
Inclusion
- Are asymptomatic adult women (aged 18 years or older);
- Are eligible to complete or have completed (within 30 days) screening ABUS and DBT exams per the site standard of care;1
- Have heterogeneously dense and extremely dense breasts (BI-RADS C or D, respectively) or are determined to have dense breasts prior to the study on initial screening mammography;
- Are able and willing to participate.
Exclusion
- 1\. Have a breast cancer diagnosis (with or without metastasis) or are being treated for breast cancer within the year prior to the study.
Key Trial Info
Start Date :
July 12 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 25 2019
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT03417024
Start Date
July 12 2018
End Date
January 25 2019
Last Update
September 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Chicago
Chicago, Illinois, United States, 60637